Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

6.63

-0.08(-1.19%)

Updated at June 03 11:27AM

Currency In CNY

Valuation

Market Cap3.04B
Enterprise Value3.94B
P/E Ratio-8.1
PEG Ratio-0.38
Price/Sales Ratio3.76
Price/Book Ratio7.19
Enterprise/Revenue5.12
Enterprise/EBITDA-15.2

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.48
Operating Margin-0.44

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.62

Income Statement

Revenue900.84M
Revenue/Share1.72
Gross Profit264.37M
EBITDA-127.85M
Net Income-287.37M
Diluted EPS-0.72

Balance Sheet

Total Cash76.57M
Total Cash/Share0.19
Total Debt1.04B
Total Debt/Equity2.72
Current Ratio0.63
Book Value Per Share1.04

Price History

52-Week Change-32.35
52-Week High10.37
52-Week Low6.03
Moving Average 50 Days6.75
Moving Average 200 Days7.89

Statistics

Average Volume3.42M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.06
Last Split FactorN/A
Last Split DateN/A